Calbindin-D 28kD immunofluorescence in ventral mesencephalic neurons labeled following injections of Fluoro-Gold in nucleus accumbens subterritories: inverse relationship relative to known neurotoxin vulnerabilities.
The shell and core of the nucleus accumbens exhibit different vulnerabilities to neurotoxins. Calcium binding proteins are reported to offer some neuroprotection against excitotoxicity by suppressing or buffering intracellular calcium. Differences in the distributions of the calbindin-D 28kD (CB) and calretinin (CR) might be related to the different vulnerabilities to neurotoxins of dopaminergic neurons in the ventral mesencephalon that project to the core and medial shell of the nucleus accumbens. To address this possibility, Fluoro-Gold (FG) was injected into accumbens subterritories and numbers of retrogradely labeled neurons in the ventral tegmental area containing CB and CR immunoreactivities (ir) were expressed as a percentage of total numbers of labeled neurons. The perikaryal diameters and lengths of the immunoreactive dendrites of FG labeled neurons were also measured. About 70% and 35% of retrogradely labeled cells observed following core and medial shell injections, respectively, exhibited CB immunoreactivity. Differences were not observed in the percentages of FG labeled cells exhibiting CR immunoreactivity following medial shell (13%) and core (15%) injections. The mean perikaryal diameters and median summed lengths of dendrites of retrogradely labeled neurons containing CB were smaller than in labeled neurons lacking CB following injections in both core and medial shell of the nucleus accumbens. The data indicate that the different 6-hydroxydopamine (6-OHDA) vulnerabilities of ventral mesencephalic dopaminergic neurons are not obviously related to the presence of CB and CR.
Tan
Y
Y
Department of Anatomy and Neurobiology, Saint Louis University School of Medicine, 1402 S. Grand Blvd., Saint Louis, MO 63104, USA.
Williams
E S
ES
Zahm
D S
DS
D000818:Animals; D064032:Calbindin 2; D064026:Calbindins; D048429:Cell Size; D005455:Fluorescent Antibody Technique; D005456:Fluorescent Dyes; D008297:Male; D009474:Neurons / Q000737:chemistry / Q000166:cytology / Q000201:enzymology; D009498:Neurotoxins; D009714:Nucleus Accumbens / Q000737:chemistry* / Q000166:cytology; D016627:Oxidopamine; D051381:Rats; D017207:Rats, Sprague-Dawley; D064030:S100 Calcium Binding Protein G / Q000032:analysis*; D013266:Stilbamidines; D013565:Sympatholytics; D014446:Tyrosine 3-Monooxygenase / Q000032:analysis; D017557:Ventral Tegmental Area / Q000737:chemistry* / Q000166:cytology
C049774:2-hydroxy-4,4'-diamidinostilbene, methanesulfonate salt; C576512:Calb2 protein, rat; D064032:Calbindin 2; D064026:Calbindins; D005456:Fluorescent Dyes; D009498:Neurotoxins; D064030:S100 Calcium Binding Protein G; D013266:Stilbamidines; D013565:Sympatholytics; D016627:Oxidopamine; D014446:Tyrosine 3-Monooxygenase